research
Treatment of Cognitive Impairment in Schizophrenia
Impairments in everyday functional outcomes are very common in people with schizophrenia and these impairments are associated with deficits in cognitive functioning. Cognitive enhancement has been proposed as a pathway to disability reduction. This pathway has been clearly defined in terms of the required clinical trials methods, with primary (cognitive) and secondary (functional) outcome measures well validated. Second generation (Newer, Atypical) antipsychotic medications have been thoroughly evaluated with their cognitive enhancement potential. Read more about this session.
2010-2011 Psychiatric Pharmacy Review Course - ACPE Credit Only
The Psychiatric Pharmacy Review Course (Review Course) is an excellent course of study and resource for those seeking a review of psychopharmacology and current standards of care. Read more about this session.
Symptom specificity in the acute treatment of Major Depressive Disorder: A re-analysis of the treatment of depression collaborative research program
Publication year: 2012Source:Journal of Affective Disorders, Volume 137, Issues 1–3Jeremy G. Stewart, Kate L. Harkness